日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series

SARS-CoV-2感染合并慢性治疗的GIST患者血浆伊马替尼暴露量增加及毒性反应:病例系列研究

Gagno, Sara; Posocco, Bianca; Orleni, Marco; Cecchin, Eleonora; Fumagalli, Arianna; Guardascione, Michela; Buonadonna, Angela; Polesel, Jerry; Puglisi, Fabio; Toffoli, Giuseppe; Cecchin, Erika

Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring

定量分析体积干血斑中的来曲唑、帕博西尼、瑞博西尼、阿贝西利及其代谢物:用于治疗药物监测的LC-MS/MS方法的开发与验证

Cecchin, Eleonora; Orleni, Marco; Gagno, Sara; Montico, Marcella; Peruzzi, Elena; Roncato, Rossana; Gerratana, Lorenzo; Corsetti, Serena; Puglisi, Fabio; Toffoli, Giuseppe; Cecchin, Erika; Posocco, Bianca

Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions

探索帕博西尼在HR+/HER2-转移性乳腺癌中的药代动力学变异性:重点关注年龄、肾功能和药物-基因相互作用

Peruzzi, Elena; Posocco, Bianca; Gerratana, Lorenzo; Nuti, Margherita; Orleni, Marco; Gagno, Sara; De Mattia, Elena; Puglisi, Fabio; Cecchin, Erika; Toffoli, Giuseppe; Roncato, Rossana

Pharmacology and pharmacokinetics of tazemetostat

tazemetostat 的药理学和药代动力学

Orleni, Marco; Beumer, Jan H

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring

LC-MS/MS 方法定量分析人血浆和干血斑中的 PARP 抑制剂 Olaparib、Rucaparib 和 Niraparib:治疗药物监测的开发、验证和临床验证

Giovanni Canil, Marco Orleni, Bianca Posocco, Sara Gagno, Alessia Bignucolo, Marcella Montico, Rossana Roncato, Serena Corsetti, Michele Bartoletti, Giuseppe Toffoli

Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring

聚(ADP-核糖)聚合酶抑制剂定量生物分析方法:治疗药物监测综述

Orleni, Marco; Canil, Giovanni; Posocco, Bianca; Gagno, Sara; Toffoli, Giuseppe

The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure

利用治疗药物监测发现一种被忽视的药物相互作用,导致伊马替尼治疗失败。

Gagno, Sara; Buonadonna, Angela; Dalle Fratte, Chiara; Guardascione, Michela; Zanchetta, Martina; Posocco, Bianca; Orleni, Marco; Canil, Giovanni; Roncato, Rossana; Cecchin, Erika; Toffoli, Giuseppe

An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer

整合药理咨询方法指导转移性乳腺癌 CDK4/6 抑制剂治疗决策

Roncato, Rossana; Gerratana, Lorenzo; Palmero, Lorenza; Gagno, Sara; Poetto, Ariana Soledad; Peruzzi, Elena; Zanchetta, Martina; Posocco, Bianca; De Mattia, Elena; Canil, Giovanni; Alberti, Martina; Orleni, Marco; Toffoli, Giuseppe; Puglisi, Fabio; Cecchin, Erika

A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring

一种快速、简便、灵敏的液相色谱-串联质谱法(LC-MS/MS)用于人血浆中乐伐替尼的定量分析,以用于治疗药物监测

Zanchetta, Martina; Iacuzzi, Valentina; Posocco, Bianca; Bortolin, Giorgia; Poetto, Ariana Soledad; Orleni, Marco; Canil, Giovanni; Guardascione, Michela; Foltran, Luisa; Fanotto, Valentina; Puglisi, Fabio; Gagno, Sara; Toffoli, Giuseppe

Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application

一种用于临床应用的新型LC-MS/MS方法,可同时定量分析人血浆中的帕博西尼、瑞博西尼和来曲唑。

Posocco, Bianca; Buzzo, Mauro; Poetto, Ariana Soledad; Orleni, Marco; Gagno, Sara; Zanchetta, Martina; Iacuzzi, Valentina; Guardascione, Michela; Puglisi, Fabio; Basile, Debora; Pelizzari, Giacomo; Marangon, Elena; Toffoli, Giuseppe